Ameliorating effects of andrographis paniculata extract against cyclophosphamide-induced toxicity in mice

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 4, 2006, Pages 609-614

  Sheeja, K ^a   Kuttan, G ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Andrographis paniculata; Antioxidants; Cyclophosphamide; Cytokines; Toxicity

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; CYTOKINE; PROTECTIVE AGENT;

ANDROGRAPHIS; ANIMAL; ARTICLE; BONE MARROW CELL; DRUG EFFECT; DRUG TOXICITY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; METHODOLOGY; MOUSE; ORGAN SIZE; PHYTOTHERAPY; RANDOMIZATION;

ANDROGRAPHIS; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW CELLS; CYCLOPHOSPHAMIDE; CYTOKINES; DRUG TOXICITY; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; ORGAN SIZE; PHYTOTHERAPY; PROTECTIVE AGENTS; RANDOM ALLOCATION;

EID: 33947541478     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bancroft JD, Cook HC (1984). Manual of Histological Techniques. Churchill Livingston, London, pp 171-174.
2. Bergmeyer HU, Bernt E (1980). Colorimentic methods for aspartate and alanine aminotranferases. In:Practical Clinical Biochemistry,Varley H, Gowenlock AH, Bell M(eds). William Heinemann Medical Books, London, pp741-742.
3. Borish L, Rosenwasser LJ (1996). Update on cytokines. J Allergy Clin Immunol, 97, 719-34.
4. Colvin OM (1997). Alkylating agents and platinum antitumor compounds. In: Holland, JF, Frei E, Bast RC, Kufe DN, Morton DL, Weichselbaum RR (eds). Cancer Medicine. Williams & Wilkins, Baltimore, pp 949-951.
5. Davis L, Kuttan G (1998). Suppressive effect of cyclophosphamideinduced toxicity by Withania somnifera extract in mice. Immunopharmacol Immunotoxicol, 62,695-703.
6. Diwanay S, Chitre D, Patwardhan B (2004). Immunoprotection by botanical drugs in cancer chemotherapy. J Ethnopharmacol, 90, 49-55.
7. Dunlop RJ, Campbell CW (2000). Cytokines and advanced cancer. J Pain Symp Manag, 20, 214-32.
8. Ehrhacat RO, Ludviksson BR, Gray B, Neurath M, Strober W (1997). Induction and prevention of chronic inflammation in IL-2 deficent mice. J Immunol, 158, 566-571
9. Fishman P, Bar-yehuda S, Barer F, et al (2001). The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res, 269, 230-6.
10. Griffin JC (1988). Clinical applications of colony stimulating factors. Oncology, 2, 15-23.
11. Gupta AK,(2004). Review on Indian Medicinal Plants, ICMR, NewDelhi. Vol1 (Ard-Alli), pp 294-295.
12. Haque R, Bin-Hafeez B, Parvez S, et al (2003). Aqueous extract of Walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Human Exp Toxicol, 22,473-480.
13. King EJ, Amstrong AR (1980). Method of King and Amstrong. In: Practical Clinical Biochemistry, Varley H, Gowenlock AH, Bell M (eds). William Heinemann Medical books Ltd, London, pp 897-899.
14. Kumar V, Abbas AK, Fausto N (2004). Pathologic Basis of Diseases. Saunders publishers, Philadelphia, Penysylvania, pp 828-830.
15. Ma Q, Kineer K (2002). Chemoprotection by phenolic antioxidants. J Biol Chem, 277, 2477-2484.
16. Manesh C, Kuttan G (2005). Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine, 12, 487-493.
17. Moron MA, De Pierre JW, Mannervick B (1979). Levels of glutathione, glutathione reductase, Glutathione-S-transferase activities in rat liver. Biochim Biophys Acta, 582, 67-68.
18. Ohkawa H, Oshishi N, Yagi K (1979). Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351-358.
19. Salvin RE, Millan JC, Mullins GM (1975). Pathology of high dose intermittent cyclophosphamide therapy. Hum Pathol, 6, 693-9.
20. Samir M, El Kholy NM (1999).Thiobarbituric acid reactive substance in patients with laryngeal cancer. Clin Otolarynggol, 24, 232-4.
21. Seven A, Civelek S, Inci E, Korkut N, Burcak G (1999) Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem, 32, 369-73.
22. Sheeja K, Shihab PK, Kuttan G (2006). Antioxidant and anti inflammatory activities of the plant Andrographis paniculata. Immunopharmacol Immunotoxicol, 28, 129-40.
23. Theze J, Alzari PM, Bertoglio J(1996). Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today, 18, 487-92.
24. Trivedi N, Rawal UM (1998). Effect of aqueous sxtract of Andrographis paniculata on liver tumor. Ind J Pharmacol, 30, 318-22.
25. Trivedi N, Rawal UM (2000). Hepatoprotective and toxicological evaluation of Andrographis paniculata on severe liver damage. Ind J Exp Pharmacol, 32, 288-93.
26. Trivedi N, Rawal UM (2001). Hepatoprotective and antioxidant property of Andrographis paniculata (Nees) in BHC induced liver damage in mice. Ind J Exp Biol, 39, 41-46.
27. Zhang XF, Tan BK (2000). Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabeticrats. Acta Pharmacol Sin, 21, 1157-64.